Description
Mod GRF and Hexarelin is a research peptide blend that integrates GHRH receptor activation and ghrelin receptor signaling to study GH release mechanisms. Mod GRF (CJC-1295 no DAC) engages cAMP/PKA pathways in pituitary somatotrophs, while Hexarelin activates GHS-R1a, enhancing calcium-dependent exocytosis. The combination is used in mechanistic investigations of peptide receptor cooperation and endocrine signaling cascades.
For research use only. Not for human consumption.
References:
Ghigo E et al., Eur J Endocrinol, 2001 145(1):1–10
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171




Reviews
There are no reviews yet.